Abstract
Non-transferrin bound iron (NTBI) is known to facilitate reactive oxygen species generation which contributes to the development of tissue damage observed in various disorders like hemolytic anemia, hemochromatosis, diabetes mellitus or many forms of neonatal central nervous system damage. Here we are summarizing information about biochemical nature of NTBI and review methods developed for its detection in biological material. Ability to detect NTBI concentration is likely to become an essential tool when it comes to diagnosis of diseases characterized by excessive iron accumulation. In contrast to routinely used parameters such as transferrin saturation or ferritin concentration, NTBI is not affected by inflammatory responses which makes it a reliable indicator. Unfortunately, we are still lacking validated laboratory methods to detect NTBI in biological fluids.
Keywords: Non-transferrin bound iron, Bleomycin, Nitrilotriacetic acid, Desferrioxamine, Hemochromatosis, Clinical Implications, Bacterial siderophore desferrioxamine (DFO), Myelodysplastic syndromes (MDS), Thalassemia
Current Pharmaceutical Analysis
Title: Non-Transferrin Bound Iron - Determination in Biological Material and Clinical Implications
Volume: 7 Issue: 4
Author(s): Artur Slomka, Katarzyna Piotrowska, Marcin Koba and Ewa Zekanowska
Affiliation:
Keywords: Non-transferrin bound iron, Bleomycin, Nitrilotriacetic acid, Desferrioxamine, Hemochromatosis, Clinical Implications, Bacterial siderophore desferrioxamine (DFO), Myelodysplastic syndromes (MDS), Thalassemia
Abstract: Non-transferrin bound iron (NTBI) is known to facilitate reactive oxygen species generation which contributes to the development of tissue damage observed in various disorders like hemolytic anemia, hemochromatosis, diabetes mellitus or many forms of neonatal central nervous system damage. Here we are summarizing information about biochemical nature of NTBI and review methods developed for its detection in biological material. Ability to detect NTBI concentration is likely to become an essential tool when it comes to diagnosis of diseases characterized by excessive iron accumulation. In contrast to routinely used parameters such as transferrin saturation or ferritin concentration, NTBI is not affected by inflammatory responses which makes it a reliable indicator. Unfortunately, we are still lacking validated laboratory methods to detect NTBI in biological fluids.
Export Options
About this article
Cite this article as:
Slomka Artur, Piotrowska Katarzyna, Koba Marcin and Zekanowska Ewa, Non-Transferrin Bound Iron - Determination in Biological Material and Clinical Implications, Current Pharmaceutical Analysis 2011; 7 (4) . https://dx.doi.org/10.2174/157341211797458014
DOI https://dx.doi.org/10.2174/157341211797458014 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Developments in the Treatment of Alcoholic Chronic Pancreatitis
Current Drug Abuse Reviews Platelets: Their Potential Contribution to the Generation of Beta-amyloid Plaques in Alzheimer’s Disease
Current Neurovascular Research Intracoronary Brachytherapy - Clinical State and Pathophysiological Considerations
Current Pharmaceutical Design Chemical Changes in Dairy Products Resulting from Cholesterol Removal Using Beta Cyclodextrins
Current Nutrition & Food Science Acute Toxicity Analysis and Antidiabetic Effect of the Moroccan Spider Flower (<i>Cleome Arabica</i> L.) in Normal and Sreptozotocin-Induced Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Dissolution Rate Enhancement of Repaglinide Using Dietary Fiber as a Promising Carrier
Current Drug Delivery Recent Advances on 3-Hydroxyflavone Derivatives: Structures and Properties
Mini-Reviews in Medicinal Chemistry Is Metabolic Syndrome Associated to HIV Infection Per Se? Results from the HERMES Study
Current HIV Research Cardiovascular Changes in Menopause
Current Cardiology Reviews Activity-Based Proteomics of Lipolytic Enzymes
Current Drug Discovery Technologies Roles of Orexin in Regulation of Energy Homeostasis
Current Medicinal Chemistry - Central Nervous System Agents Long-Term Safety from the Raltegravir Clinical Development Program
Current HIV Research Effect of Fibrin-binding Synthetic Oligopeptide on the Healing of Full-thickness Skin Wounds in Streptozotocin-induced Diabetic Rats
Current Pharmaceutical Design The Clinical and Biological Relationship between Type II Diabetes Mellitus and Alzheimers Disease
Current Alzheimer Research Beyond Cholesterol Lowering: Pleiotropic Effects of Bile Acid Binding Resins Against Cardiovascular Disease Risk Factors in Patients with Metabolic Syndrome
Current Vascular Pharmacology Lipid Rafts and Redox Regulation of Cellular Signaling in Cholesterol Induced Atherosclerosis
Current Cardiology Reviews New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design The Functional Logic of Cytosolic 5’-Nucleotidases.
Current Medicinal Chemistry The Role of Antiplatelet Agents in the Management of Patients Receiving Intracardiac Closure Devices
Current Pharmaceutical Design Breast Cancer: Biological Characteristics in Postmenopausal Type 2 Diabetic Women. Identification of Therapeutic Targets
Current Drug Targets - Immune, Endocrine & Metabolic Disorders